Skip to main content
Autobound logo

What Cencora's latest 10-Q says: 9 signals

Cencora filed its latest 10-Q with the SEC on Aug 5, 2026. It discusses acquisition completed, capex increase and CFO change.

Public (COR)Pharmaceutical Manufacturing10,000+ employeescencora.comLinkedIn

Filed
Aug 5, 2026
Filings
3
Signals
29

10-Q · latest 10

What Cencora's 10-Q filings say

  1. 10-Q

    Filed · 9 signals

    SEC EDGAR

  2. 10-Q

    Filed · 8 signals

    SEC EDGAR

Earlier 10-Q filings

Showing 10 of 29 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Cencora earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Investing in digital transformation using AI for demand forecastingThe company is executing a digital transformation initiative focused on combining business process improvement with technology. A key example is the use of AI to improve demand forecasting across its network, which helps improve planning and enhance product availability. This indicates a budget and strategic focus on AI/ML platforms, data analytics tools, and process automation software to...
Raising FY2026 EPS and operating income growth guidanceReflecting strong performance and confidence in execution, the company raised its full-year adjusted EPS guidance to a range of $17.75 to $17.95. It also raised the bottom end of its consolidated operating income growth guidance to a new range of 13% to 14%, with the U.S. segment's operating income growth now projected at 14.5% to 15.5%.
Q3 revenue up 5% to $84.8B, adjusted operating income grows 17%Consolidated revenue reached $84.8 billion, a 5% increase, driven by growth in both U.S. and International segments. Adjusted operating income showed strong growth of 17% to $1.2 billion, with adjusted EPS growing 12%. The U.S. Healthcare Solutions segment revenue was $74.9 billion (+5%), while the International Healthcare Solutions segment revenue was $7.7 billion (+6%).
Merging MWI Animal Health with Covetrus in strategic divestitureCencora has agreed to merge its MWI Animal Health business with Covetrus as part of its strategy to focus on its core pharmaceutical business. This divestiture is expected to create a $150 million operating income headwind in fiscal 2027. Such a large-scale transaction will require significant consulting, IT, and legal services to manage the separation and integration processes.
Facing $2.4B revenue headwind from manufacturer list price reductionsThe U.S. Healthcare Solutions segment experienced a significant $2.4 billion negative impact on revenue growth due to manufacturer list price reductions. This external pressure creates a strong incentive for efficiency, cost management, and developing value-added services to protect margins, making the company receptive to solutions that improve operational effectiveness and profitability.
Using AI for demand forecasting to improve planning and serviceAs part of a broader digital transformation, the company is actively using AI to better anticipate product needs across its network and understand demand drivers. This technology investment is aimed at improving planning, enhancing product availability, and simplifying manual processes, allowing employees to focus on higher-value problem-solving with partners.

Signal API · MCP

Track Cencora with the Signal API

One POST /v1/companies/enrich call with cencora.com returns Cencora 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"cencora.com","signal_types":["sec-10q"],"limit":20}'

Same industry

10-Q at related companies

Questions about Cencora 10-Q

When did Cencora file its latest 10-Q?
Cencora filed its latest 10-Q on Aug 5, 2026. The one before it was filed on May 6, 2026.
What did Cencora disclose in its latest 10-Q?
From the filing dated Aug 5, 2026: Cencora commits over $1.2B to ERP upgrade and digital transformation projects.
What did Cencora say on its recent earnings calls?
Q3 FY2026: Investing in digital transformation using AI for demand forecasting (dated Aug 5, 2026).
Where can I read Cencora's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →